tiprankstipranks
Trending News
More News >
Elicera Therapeutics AB (SE:ELIC)
:ELIC
Advertisement

Elicera Therapeutics AB (ELIC) Revenue

Compare
3 Followers

Elicera Therapeutics AB Revenue

Elicera Therapeutics AB had a revenue of 2.70M in the quarter ending Jun 30, 2025, with 1131.92%. This bring the company's revenue in the last twelve months to 6.02M, Decreased 39.60%. In the fiscal year ending Dec 31, 2024, Elicera Therapeutics AB had annual revenue of 7.13M with -36.53% growth.
Revenue (ttm)
6.02M
Revenue Growth
P/S Ratio
49.43
Revenue/Employee
€3,564,000
Employees
2
Market Cap
€352.37M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
7.13M-4.10M+63.47%
Dec 31, 2023
11.23M9.95M+877.34%
Dec 31, 2022
1.28M1.28M+218,430.03%
Dec 31, 2021
587.00-58,700.00%
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis